Bianca Romo
Bianca’s studies focus on the identification and functional analysis of novel protein modulators of estrogen receptor alpha in breast cancer cells.
Steven Tau
Steven is leveraging metabolic and REDOX vulnerabilities in residual breast cancers cells that remain following anti-estrogen therapy to develop novel therapeutic approaches.
Alyssa Roberts
Alyssa aims to uncover mechanisms of DNA damage in breast cancer and explore novel combination therapies to treat recurrent disease. She received her B.S. in Biochemistry from North Dakota State University in 2021 before starting her Ph.D. in Cancer Biology at Dartmouth.
Lauren Ferridge
Lauren is evaluating the effects of oxidative stress in ER+ breast cancer.
Alexa Warren
Alexa is exploring the molecular mechanisms that underly the sensitivity of breast cancer cells to novel treatment combinations designed to overcome resistance to current therapies.